Wesbanco Bank Inc Amgen Inc Transaction History

Wesbanco Bank Inc

$2.89 Billion
Q3 2024

A detailed history of Wesbanco Bank Inc transactions in Amgen Inc stock. As of the latest transaction made, Wesbanco Bank Inc holds 52,019 shares of AMGN stock, worth $15.1 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

52,019

Previous 55,855 6.87%

Holding current value

$15.1 Million

Previous $17.5 Million 3.95%

% of portfolio

0.58%

Previous 0.66%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$309.38 - $337.38 $1.19 Million - $1.29 Million	-3,836 Reduced 6.87%	52,019 $16.8 Million
Q2 2024 Jul 11, 2024	BUY	$262.75 - $319.31 $81,452 - $98,986	310 Added 0.56%	55,855 $17.5 Million
Q1 2024 Apr 23, 2024	BUY	$268.87 - $324.56 $6.81 Million - $8.22 Million	25,322 Added 83.78%	55,545 $15.8 Million
Q4 2023 Feb 16, 2024	SELL	$255.7 - $288.46 $6.65 Million - $7.5 Million	-26,015 Reduced 46.26%	30,223 $8.7 Million
Q3 2023 Dec 11, 2023	SELL	$218.65 - $271.46 $338,470 - $420,220	-1,548 Reduced 2.68%	56,238 $15.1 Million
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $237,839 - $281,240	-1,110 Reduced 1.88%	57,786 $12.8 Million
Q1 2023 Apr 21, 2023	SELL	$225.79 - $275.2 $139,989 - $170,624	-620 Reduced 1.04%	58,896 $14.2 Million
Q4 2022 Jan 18, 2023	BUY	$229.03 - $291.01 $6.12 Million - $7.77 Million	26,710 Added 81.42%	59,516 $15.6 Million
Q3 2022 Oct 13, 2022	SELL	$224.46 - $253.15 $6.41 Million - $7.23 Million	-28,579 Reduced 46.56%	32,806 $7.4 Million
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $325,301 - $362,003	-1,410 Reduced 2.25%	61,385 $14.9 Million
Q1 2022 Apr 25, 2022	SELL	$219.27 - $242.57 $6.94 Million - $7.68 Million	-31,649 Reduced 33.51%	62,795 $15.2 Million
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $1.66 Million - $1.9 Million	-8,347 Reduced 8.12%	94,444 $21.2 Million
Q3 2021 Oct 12, 2021	SELL	$212.27 - $248.7 $23,137 - $27,108	-109 Reduced 0.11%	102,791 $21.9 Million
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $56,759 - $62,971	-243 Reduced 0.24%	102,900 $25.1 Million
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $656,409 - $764,938	-2,958 Reduced 2.79%	103,143 $25.7 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $546,030 - $607,230	2,327 Added 2.24%	106,101 $27 Million
Q2 2020 Jul 14, 2020	BUY	$197.81 - $242.74 $223,525 - $274,296	1,130 Added 1.1%	103,774 $24.5 Million
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $1.03 Million - $1.37 Million	-5,664 Reduced 5.23%	102,644 $20.8 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $133,960 - $172,185	-708 Reduced 0.65%	108,308 $26.1 Million
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $139,810 - $167,521	803 Added 0.74%	109,016 $21.1 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $427,085 - $500,640	2,562 Added 2.42%	108,213 $19.9 Million
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $737,226 - $831,014	4,076 Added 4.01%	105,651 $20.1 Million
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $262,426 - $306,335	-1,471 Reduced 1.43%	101,575 $19.8 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $662,597 - $746,990	-3,576 Reduced 3.35%	103,046 $21.4 Million
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $111,585 - $125,334	672 Added 0.63%	106,622 $19.7 Million
Q1 2018 May 18, 2018	BUY	$169.43 - $198.0 $7.6 Million - $8.88 Million	44,840 Added 73.38%	105,950 $18.1 Million
Q4 2017 Feb 01, 2018	SELL	$168.79 - $188.59 $7.66 Million - $8.56 Million	-45,387 Reduced 42.62%	61,110 $10.6 Million
Q3 2017 Nov 02, 2017	SELL	$167.29 - $191.0 $49,350 - $56,345	-295 Reduced 0.28%	106,497 $19.9 Million
Q2 2017 Aug 08, 2017	BUY	N/A	106,792	106,792 $18.4 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.

Account

Wesbanco Bank Inc Amgen Inc Transaction History